Lonza to Host Free Webinar: Medical Devices: Guidelines for Performing the Bacterial Endotoxins Test (BET)

Hits:1451 Date: 3/31/2016

Cologne (DE) / Walkersville, MD (USA), 30 March 2016 – Lonza will host a free 60-minute webinar on 12 April 2016 and 13 April 2016 titled “Medical Devices: Guidelines for Performing the Bacterial Endotoxins Test (BET).”

During the webinar QC professionals responsible for endotoxin testing will have the opportunity to learn from Lonza’s Scientific Support Specialists, who will discuss the following topics:

What constitutes a device?
How are Endotoxin Release Limits (ERL) calculated?
How is a sampling plan established?
How can suitability testing (test for interfering factors) be conducted?

The webinar will be hosted on two consecutive days in order to effectively support users across the globe. Interested parties can register to attend the free webinar by selecting the link associated with their preferred time slot below:

Tuesday, 12 April 2016 – 11 AM PDT (Los Angeles) / 2 PM EDT (New York)

https://attendee.gotowebinar.com/register/3348249673816942849

Speaker: Travis Wallace, Scientific Support Specialist, Lonza

Wednesday, 13 April 2016 – 9 AM BST (London) / 10 AM CEST (Berlin) / 5 PM JST (Tokyo)

https://attendee.gotowebinar.com/register/5735175068509652225

Speaker: Dr. Ingo Ciolkowski, Scientific Support Specialist, Lonza

Each webinar includes a Q&A session, and all registered participants will receive a PDF copy of the presentation with access to the recorded webinar shortly after the webinar takes place.

Lonza has been providing endotoxin detection products and services for nearly 40 years and has been leading the way in innovation for products, methods and software. Further information is available on http://www.lonza.com/products-services/pharma-biotech/endotoxin-detection.

About Lonza

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.

Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B3 compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of CHF 3.8 billion in 2015 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.

Lonza Contact Information

Lonza Cologne GmbH

Manager Marketing

Communications

Petra Haberkamm

Tel +49 221 991990

Fax +49 221 99199498

marcom.lbs@lonza.com

Lonza Group Ltd

Head Corporate

Communications

Dominik Werner